Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00285259
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2006-01-30
Brief Title:
Cytomegalovirus CMV Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant HCT
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
| Chronic Myelogenous Leukemia |
| Acute Lymphoblastic Leukemia |
| Acute Myelogenous Leukemia |
| Hodgkins Lymphoma |
| Non-Hodgkins Lymphoma |
Keywords:
| Name | View |
|---|---|
| cytomegalovirus infection | View |
| infectious disease | View |
| viremia | View |
| cytomegalovirus disease | View |
| stem cell transplant | View |
| allogeneic | View |
| bone marrow transplant | View |
| hematopoietic cell transplant | View |
| Acute Lymphoblastic Leukemia | View |
| Chronic Myelogenous Leukemia | View |
| Acute Myelogenous Leukemia | View |
| Hodgkins Lymphoma | View |
| Non-Hodgkins Lymphoma | View |
| Myelodysplastic Syndrome | View |